Skip to main content
Top
Published in: Rheumatology International 8/2010

01-06-2010 | Case Report

Familial Behçet’s disease

Authors: Sema Yilmaz, Kadriye Akar Cimen

Published in: Rheumatology International | Issue 8/2010

Login to get access

Abstract

Behçet’s disease (BD) is a multisystemic vasculitis syndrome characterized by a course of remissions and exacerbations of unpredictable frequency and duration. The disease has a worldwide distribution, but the majority of cases cluster along the ancient Silk Road, which extends from eastern Asia to the Mediterranean basin. The etiopathogenesis of BD is still unknown, but familial aggregation and peculiar geographical distribution have been regarded as evidence supporting genetic influence on the pathogenesis of BD. In this article, we describe a patient with BD, who had four members of his family associated with BD.
Literature
1.
go back to reference Muzuki N, Ionoko H, Ohno S (1997) Pathogenesis gene responsible for the predisposition to the Behçet’s disease. Int Rev Immunol 14:33–48 Muzuki N, Ionoko H, Ohno S (1997) Pathogenesis gene responsible for the predisposition to the Behçet’s disease. Int Rev Immunol 14:33–48
3.
go back to reference Nishiyama M, Nakae K, Kuriyama T, Hashimato M, Hsu ZN (2002) A study among related pairs of Japanese patients with familial Behçet’s disease: group comparisons by interval of disease onsets. J Rheumatol 29:743–747PubMed Nishiyama M, Nakae K, Kuriyama T, Hashimato M, Hsu ZN (2002) A study among related pairs of Japanese patients with familial Behçet’s disease: group comparisons by interval of disease onsets. J Rheumatol 29:743–747PubMed
6.
go back to reference Zouboulis CC (1999) Epidemiology of adamantiades-Behçet’s disease. Ann Med Intern (Paris) 150:488–498 Zouboulis CC (1999) Epidemiology of adamantiades-Behçet’s disease. Ann Med Intern (Paris) 150:488–498
7.
go back to reference Zouboulis CC, Kotter I, Djawari D et al (1997) Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411–422PubMed Zouboulis CC, Kotter I, Djawari D et al (1997) Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411–422PubMed
8.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
9.
go back to reference Altaç M, Tuzun M, Yurdakul S, Bınyıldız P, Yazıcı H (1982) The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet’s disease: a double-blind study by independent observers. Acta Derm Venereol 62:158–159PubMed Altaç M, Tuzun M, Yurdakul S, Bınyıldız P, Yazıcı H (1982) The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet’s disease: a double-blind study by independent observers. Acta Derm Venereol 62:158–159PubMed
10.
13.
14.
go back to reference Salvarani C, Boiardi L, Casali B et al (2004) Vascular endothelial growth factor gene polymorphisms in Behçet’s disease. J Rheumatol 31:1785–1789PubMed Salvarani C, Boiardi L, Casali B et al (2004) Vascular endothelial growth factor gene polymorphisms in Behçet’s disease. J Rheumatol 31:1785–1789PubMed
Metadata
Title
Familial Behçet’s disease
Authors
Sema Yilmaz
Kadriye Akar Cimen
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1036-y

Other articles of this Issue 8/2010

Rheumatology International 8/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.